Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis

Abstract Creating fast, non-invasive, precise, and specific diagnostic tests is crucial for enhancing cancer treatment outcomes. Among diagnostic methods, those relying on nucleic acid detection are highly sensitive and specific. Recent developments in diagnostic technologies, particularly those lev...

Full description

Saved in:
Bibliographic Details
Main Authors: Zahra Farshchian Yazdi, Shahrzad Roshannezhad, Samaneh Sharif, Mohammad Reza Abbaszadegan
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-024-05908-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841559115388682240
author Zahra Farshchian Yazdi
Shahrzad Roshannezhad
Samaneh Sharif
Mohammad Reza Abbaszadegan
author_facet Zahra Farshchian Yazdi
Shahrzad Roshannezhad
Samaneh Sharif
Mohammad Reza Abbaszadegan
author_sort Zahra Farshchian Yazdi
collection DOAJ
description Abstract Creating fast, non-invasive, precise, and specific diagnostic tests is crucial for enhancing cancer treatment outcomes. Among diagnostic methods, those relying on nucleic acid detection are highly sensitive and specific. Recent developments in diagnostic technologies, particularly those leveraging Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), are revolutionizing cancer detection, providing accurate and timely results. In clinical oncology, liquid biopsy has become a noninvasive and early-detectable alternative to traditional biopsies over the last two decades. Analyzing the nucleic acid content of liquid biopsy samples, which include Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Circulating Cell-Free RNA (cfRNA), and tumor extracellular vesicles, provides a noninvasive method for cancer detection and monitoring. In this review, we explore how the characteristics of various Cas (CRISPR-associated) enzymes have been utilized in diagnostic assays for cancer liquid biopsy and highlight their main applications of innovative approaches in monitoring, as well as early and rapid detection of cancers.
format Article
id doaj-art-0a97efec7ea342f5ad5ad8f64e070c7a
institution Kabale University
issn 1479-5876
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj-art-0a97efec7ea342f5ad5ad8f64e070c7a2025-01-05T12:44:21ZengBMCJournal of Translational Medicine1479-58762024-12-0122112710.1186/s12967-024-05908-yRecent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysisZahra Farshchian Yazdi0Shahrzad Roshannezhad1Samaneh Sharif2Mohammad Reza Abbaszadegan3Department of Medical Genetics, Faculty of Medicine, Shahid Sadoughi University of Medical SciencesDepartment of Science, Mashhad Branch, Islamic Azad UniversityMedical Genetics Research Center, Mashhad University of Medical SciencesDepartment of Medical Genetics, Faculty of Medicine, Mashhad University of Medical SciencesAbstract Creating fast, non-invasive, precise, and specific diagnostic tests is crucial for enhancing cancer treatment outcomes. Among diagnostic methods, those relying on nucleic acid detection are highly sensitive and specific. Recent developments in diagnostic technologies, particularly those leveraging Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), are revolutionizing cancer detection, providing accurate and timely results. In clinical oncology, liquid biopsy has become a noninvasive and early-detectable alternative to traditional biopsies over the last two decades. Analyzing the nucleic acid content of liquid biopsy samples, which include Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Circulating Cell-Free RNA (cfRNA), and tumor extracellular vesicles, provides a noninvasive method for cancer detection and monitoring. In this review, we explore how the characteristics of various Cas (CRISPR-associated) enzymes have been utilized in diagnostic assays for cancer liquid biopsy and highlight their main applications of innovative approaches in monitoring, as well as early and rapid detection of cancers.https://doi.org/10.1186/s12967-024-05908-yCRISPR-CasCancerLiquid biopsyDiagnosis
spellingShingle Zahra Farshchian Yazdi
Shahrzad Roshannezhad
Samaneh Sharif
Mohammad Reza Abbaszadegan
Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis
Journal of Translational Medicine
CRISPR-Cas
Cancer
Liquid biopsy
Diagnosis
title Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis
title_full Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis
title_fullStr Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis
title_full_unstemmed Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis
title_short Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis
title_sort recent progress in prompt molecular detection of liquid biopsy using cas enzymes innovative approaches for cancer diagnosis and analysis
topic CRISPR-Cas
Cancer
Liquid biopsy
Diagnosis
url https://doi.org/10.1186/s12967-024-05908-y
work_keys_str_mv AT zahrafarshchianyazdi recentprogressinpromptmoleculardetectionofliquidbiopsyusingcasenzymesinnovativeapproachesforcancerdiagnosisandanalysis
AT shahrzadroshannezhad recentprogressinpromptmoleculardetectionofliquidbiopsyusingcasenzymesinnovativeapproachesforcancerdiagnosisandanalysis
AT samanehsharif recentprogressinpromptmoleculardetectionofliquidbiopsyusingcasenzymesinnovativeapproachesforcancerdiagnosisandanalysis
AT mohammadrezaabbaszadegan recentprogressinpromptmoleculardetectionofliquidbiopsyusingcasenzymesinnovativeapproachesforcancerdiagnosisandanalysis